Home News & Events Events Workshops Workshops Page tools Share Share Share on LinkedinShare on BlueskyShare on XShare on Facebook Print Search Email Accessibility Workshop NONMEM Introduction Workshop (China Region): Applications in PK/PD Modeling (Mandarin Language) Date 3 September 2026 Time 09:00 - 12:00 Location Online/Virtual Webex Timezone Asia/Shanghai Workshop Beginners/Intermediate Online NONMEM/PDx-Pop Workshop Date 22 September 2026 - 23 September 2026 Time 09:00 - 17:00 Location Online/Virtual Webex Timezone America/New York Workshop Advanced Online NONMEM/PDx-Pop Workshop Date 24 September 2026 Time 09:00 - 17:00 Location Online/Virtual Webex Timezone America/New York Workshop New and Advanced Features of NONMEM 7.6 at ACoP 2026 In Person Workshop Date 11 October 2026 Time 08:00 - 17:00 Location Gaylord National Resort & Convention Center, Oxon Hill, Maryland, USA. Timezone America/New York In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events ASCO 2026 ISPOR EU 2026 Webinars Workshops Webinars Social media hub Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Event Webinars Event Industry Events What’s happening in ICON ICON Plc Great managers can make all the difference to your career and your day to day experience at work. At ICON, our managers play an important role in supporting people to grow, share their expertise and build confidence in ... 7 Aug View post View webpage ICON Plc Europe is emerging as an attractive route to global market access for Chinese sponsors. Early consideration of EMA requirements can help avoid costly delays and improve approval success. Read the article: https://ow.ly... 7 Aug View post View webpage ICON Plc Every successful clinical trial starts long before the first participant is enrolled. Site Selection and Activation is one of the most important, yet often overlooked, stages of clinical research. From identifying the r... 7 Aug View post View webpage ICON Plc The EU's Packaging and Packaging Waste Regulation (PPWR) is set to transform how medical device packaging is managed across Europe. While some contact-sensitive packaging benefits from targeted exemptions, medical devic... 6 Aug View post View webpage ICON Plc Preparing for Italy's new serialisation framework requires more than regulatory awareness. Marketing authorisation holders, manufacturers and supply chain partners will need to assess packaging configurations, validate ... 6 Aug View post View webpage ICON Plc Regulatory pathways for biosimilars are changing, with reduced clinical requirements placing greater emphasis on analytical comparability and manufacturing excellence. Understanding how to respond to these shifts can mak... 6 Aug View post View webpage ICON Plc As biologics, biomarker-enriched trials and real-world evidence reshape the COPD landscape, sponsors face both new opportunities and increasing complexity. Success depends on translating these advances into effective cli... 5 Aug View post View webpage ICON Plc As biotech confidence returns and deal activity accelerates, companies have an opportunity to position themselves for the next phase of growth. In a new BioPharma Dive article, Deepali Suri, President of ICON Biotech, s... 5 Aug View post View webpage ICON Plc We are proud to share that ICON has been named a Winner for Organisational Excellence for the second year running at the GCC India Workplace Innovation Summit & Awards 2026. This recognition celebrates organisations red... 5 Aug View post View webpage ICON Plc Sustainability remains central to how we operate, innovate and support our communities at ICON. Being named in TIME’s World’s Most Sustainable Companies 2026 for a second year underscores our ICON Cares’ focus on respon... 4 Aug View post View webpage ICON Plc Vaccines save millions of lives each year and help protect communities from preventable diseases. In support of National Immunisation Awareness Month, ICON is proud to have participated in 147 vaccine studies across key ... 4 Aug View post View webpage ICON Plc Policy binders aren't enough to protect patients on neurologic monoclonal antibodies (mAbs). Clinical practices must embed automated safety rules, like therapy holds for active infections, directly into EHR systems. Disc... 4 Aug View post View webpage
